Search Results 101-110 of 16853 for Amphotericin B

  1. Publications - Michael B. Phillips, M.D. - Mayo Clinic

    Decosma L, Phillips MB. Paraneoplastic hypercalcemia and other electrolyte abnormalities in localized ameloblastoma. Annals of Internal Medicine Clinical ...

  2. Hepatitis B Research Network Adult Cohort Study - Mayo Clinic

    The primary purpose of this study is to describe participants with hepatitis B virus (HBV) infection and identify factors that may cause the disease to activate ...

  3. Axicabtagene ciloleucel (intravenous route) - Side effects & uses - Mayo Clinic

    Axicabtagene ciloleucel injection is used to treat follicular lymphoma and large B-cell lymphoma (including diffuse large B-cell lymphoma [DLBCL], primary ...

  4. Publications - Maheen Z. Abidi, M.B.B.S., M.D. - Mayo Clinic

    Hepatitis B transmission/reactivation associated with Hepatitis B ... Sartain E, Schoeppler K, Crowther B ... amphotericin combination therapies. Mycoses. 2014 ...

  5. Publications - Emrys Fonseca, M.B., B.Ch., B.A.O., M.S. - Mayo Clinic

    JJ Matthews, FD Fonseca, CV Varnado. Help-seeking behaviors of African Americans after a loss Journal of Multicultural Counseling and Development. 2021; 60-71.

  6. Publications - Madeleine B. O'Keefe, M.D. - Mayo Clinic

    Kuhn AK, O'Keefe M, Kohorst M, Kalmes J, Galardy P, Walter A, Guggenberger J, Salama M, Pittock S, Martin C. Severe hypertriglyceridemia associated with ...

  7. Amanda B. Ebright, M.D. - Doctors and Medical Staff - Mayo Clinic

    Excellence in Teaching RecognitionMayo Medical School, Mayo Clinic College of Medicine and Science, Department of Education Administration.

  8. A Study Evaluating KTE-X19 in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL) (ZUMA-3) - Mayo Clinic

    ... B-precursor acute lymphoblastic leukemia (ALL). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...

  9. Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study - Mayo Clinic

    The purpose of this study is to compare the safety and effectiveness of the PMX cartridge (Toraymyxin) based on mortality at 28 days in patients with septic ...

  10. Publications - Matthew B. Anastasi, M.D. - Mayo Clinic

    Christopher ZK, Hassebrock JD, Anastasi MB, Economopoulos KJ. Hip Flexor Injuries in the Athlete. Clin Sports Med. 2021 Apr; 40(2):301-310. Epub 2021 Jan 19.